Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc. (CPHRF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CPHRF · as of Jun 9, 2026
Key Statistics
Explore Cipher Pharmaceuticals Inc. Data
cphrf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
cphrf competitorsCPHRF
ABTI
AONC
BHCCF
BHHKF
HNSBFStock Performance
Full HistoryAbout Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc. functions as a specialized pharmaceutical company based in Canada. The firm markets a diverse portfolio of therapies, including Epuris (CIP-ISOTRETINOIN), an isotretinoin f…
what is cipher pharmaceuticals inc. · cphrf stock overview · cipher pharmaceuticals inc. company profile · who is cipher pharmaceuticals inc. ceo · cphrf OTC · cipher pharmaceuticals inc. headquarters · cipher pharmaceuticals inc. business segments
About Stock Overview & Key Data
Cipher Pharmaceuticals Inc. (CPHRF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Feb 2, 2006. As of the latest trading session, CPHRF stock price is $12.14, with a market capitalization of $306.9M. The stock has returned +28.33% over the past 12 months and +10.56% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Cipher Pharmaceuticals Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Cipher Pharmaceuticals Inc. reported revenue of $51.3M and net income of $27.8M. For detailed data — including Cipher Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cipher Pharmaceuticals Inc. (CPHRF) stock price is $12.14. The stock is traded on OTC under the ticker symbol CPHRF. The 52-week range is $8.64 – $15.00.